ALPS Medical Breakthroughs ETF
SBIO
#2393
ETF rank
โ‚น13.97 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
โ‚น5,127
Share price
-0.33%
Change (1 day)
110.60%
Change (1 year)

Expense ratio and fees for ALPS Medical Breakthroughs ETF (SBIO)

Gross Expense Ratio

Gross Expense Ratio as of April 2026: 0.5%

Net Expense Ratio

Net Expense Ratio as of April 2026: 0.5%